Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.
Recordati S.p.A. has updated its stakeholders on the execution of its share buyback program, which was initiated on April 30, 2025. The program aims to purchase shares to support stock options and performance share plans for the management of the Recordati Group. As of May 9, 2025, Recordati has purchased 2,329 ordinary shares at a weighted average price of €52.5512 each, and now holds 3,136,086 own shares, representing 1.500% of its share capital. This strategic move is expected to enhance the company’s incentive plans and align management interests with those of shareholders.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. With origins in a family pharmacy in Northern Italy from the 1920s, the company offers therapeutic options in specialty and general medicine drugs, as well as treatments for rare diseases. Recordati operates in a fully integrated manner from clinical development to production, marketing, and licensing, and has a presence in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people.
YTD Price Performance: 3.06%
Average Trading Volume: 478,087
Technical Sentiment Signal: Buy
Current Market Cap: €10.76B
See more data about REC stock on TipRanks’ Stock Analysis page.